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The TspanC8 Subgroup of Tetraspanins Interacts with A
Disintegrin andMetalloprotease 10 (ADAM10) and Regulates
Its Maturation and Cell Surface Expression*□S
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Elizabeth J. Haining‡, Jing Yang‡, Rebecca L. Bailey‡, Kabir Khan‡, Richard Collier‡, Schickwann Tsai§,
Steve P. Watson¶, Jon Frampton, Paloma Garcia, and Michael G. Tomlinson‡1
From the ‡School of Biosciences, College of Life and Environmental Sciences and Schools of ¶Clinical and Experimental Medicine
and Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT,
United Kingdom and §Division of Hematology, Department of Medicine, University of Utah, Salt Lake City, Utah 84132
Background: ADAM10 is a transmembrane metalloprotease that regulates development, inflammation, cancer, and
Alzheimer disease.
Results:The TspanC8 subgroup of tetraspanin membrane proteins interacts with and promotes ADAM10maturation and cell
surface localization.
Conclusion: This study defines the TspanC8 tetraspanins as essential regulators of ADAM10.
Significance: Focusing on specific TspanC8-ADAM10 complexes may allow ADAM10 therapeutic targeting in a cell type-
and/or substrate-specific manner.
A disintegrin and metalloprotease 10 (ADAM10) is a ubiqui-
tous transmembrane metalloprotease that cleaves the extracel-
lular regions from over 40 different transmembrane target pro-
teins, including Notch and amyloid precursor protein.
ADAM10 is essential for embryonic development and is also
important in inflammation, cancer, and Alzheimer disease.
However, ADAM10 regulation remains poorly understood.
ADAM10 is compartmentalized into membrane microdomains
formed by tetraspanins, which are a superfamily of 33 trans-
membrane proteins in humans that regulate clustering and traf-
ficking of certain other transmembrane “partner” proteins. This
is achieved by specific tetraspanin-partner interactions, but it is
not clearwhich tetraspanins specifically interactwithADAM10.
The aims of this study were to identify which tetraspanins inter-
act with ADAM10 and how they regulate this metalloprotease.
Co-immunoprecipitation identified specific ADAM10 interac-
tions with Tspan5, Tspan10, Tspan14, Tspan15, Tspan17, and
Tspan33/Penumbra. These are members of the largely unstud-
ied TspanC8 subgroup of tetraspanins, all six of which pro-
moted ADAM10 maturation. Different cell types express dis-
tinct repertoires of TspanC8 tetraspanins. Human umbilical
vein endothelial cells express relatively high levels of Tspan14,
the knockdown of which reduced ADAM10 surface expression
and activity. Mouse erythrocytes express predominantly
Tspan33, andADAM10 expressionwas substantially reduced in
the absence of this tetraspanin. In contrast, ADAM10 expres-
sion was normal on Tspan33-deficient mouse platelets in which
Tspan14 is themajor TspanC8 tetraspanin. These results define
TspanC8 tetraspanins as essential regulators of ADAM10 mat-
uration and trafficking to the cell surface. This finding has
therapeutic implications because focusing on specific TspanC8-
ADAM10 complexes may allow cell type- and/or substrate-spe-
cific ADAM10 targeting.
The proteolytic cleavage, or “shedding,” of the extracellular
regions (ectodomains) of transmembrane proteins is emerging
as an important mechanism for the regulation of cell develop-
ment and function (1–3). A disintegrin and metalloprotease 10
(ADAM10)2 is a type 1 transmembrane protein that is ubiqui-
tously expressed and functions as an ectodomain sheddase for
over 40 transmembrane target proteins (4). ADAM10-deficient
mice die at embryonic day 9.5, consistent with the essential role
of ADAM10 in the cleavage and activation of Notch, which is
central to most cell fate decision-making processes during
metazoan development (5). Amyloid precursor protein is an
ADAM10 target that is central to Alzheimer disease (6). Cleav-
age of amyloid precursor protein by - and -secretases gives
rise to the pathogenic amyloid -peptide that forms the amy-
loid plaques in the brains of Alzheimer disease patients. Coun-
teracting this is the -secretase activity of ADAM10 that
cleaves amyloid precursor protein at a third site, thus prevent-
ing release of the pathogenic peptide. Indeed, transgenic over-
expression of ADAM10 prevents amyloid plaque deposition in
amousemodel of Alzheimer disease, suggesting that ADAM10
is a promising target for disease treatment in humans (6).
ADAM10 targets in the vasculature include the platelet-acti-
vating collagen receptor glycoprotein VI (7, 8) and endothelial
proteins with roles in angiogenesis and inflammation, such as
vascular endothelial growth factor receptor 2 (9), the junctional
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adhesion molecule VE-cadherin (10), and transmembrane
chemokines CX3CL1 and CXCL16 (11). Despite the impor-
tance of ADAM10, the regulation of its trafficking, activation,
and localization to targets is poorly understood. Mechanistic
characterization of these events is essential if we are to harness
the potential of ADAM10 as a therapeutic target.
The regulation of transmembrane proteins by their compart-
mentalization into membrane microdomains is a concept that
has developed over recent years through the study of neuronal
and immunological synapses, lipid rafts, caveolae, and tetraspa-
nins. The latter are a superfamily of four-transmembrane pro-
teins that number 33 in humans (12, 13). Tetraspanins possess
two extracellular regions, the larger of which has four to eight
conserved cysteine residues that form structurally important
disulfide bonds. They appear to fold into compact rod-shaped
structures that only project about 5 nm from the plasma mem-
brane and play a fundamental organizing role by self-associat-
ing to form microdomains. Specific tetraspanins recruit
so-called “partner” proteins into the microdomains. These
partners include certain integrins, immunoglobulin superfam-
ily proteins, and proteases, and in some cases, their interaction
with tetraspanins is essential for normal biosynthesis and traf-
ficking to the plasmamembrane (12, 13). Tetraspaninmicrodo-
mains can also facilitate cell adhesion and signaling by provid-
ing platforms inwhich associated proteins can be clustered. For
example, the endothelial cell adhesion molecules ICAM-1,
VCAM-1, and P-selectin require clustering by tetraspanins
CD9, CD151, and CD63, respectively, for efficient capture of
leukocytes from the circulation (14, 15). In addition, Frizzled-4
appears to require clustering by tetraspanin Tspan12 to allow
appropriate -catenin signaling for development of the retinal
vasculature in mice and humans (16–18). In contrast, vascular
development in mice is normal in the absence of CD151, but
pathological angiogenesis is defective, possibly due to the well
characterized regulation of laminin-binding integrins 31
and 61 by this tetraspanin (19). On platelets, CD151 and
Tspan32 are essential for thrombus formation in vivo (20, 21),
andTspan33 (previously namedPenumbra) is required for nor-
mal erythropoiesis (22), although the mechanisms responsible
for these phenotypes remain unclear.
ADAM10 was recently shown to predominantly localize to
tetraspanin microdomains in human leukocyte cell lines (23).
In addition, tetraspanin antibodies could promote ADAM10
activity as measured by shedding of two ADAM10 targets,
TNF- and EGF (23). A second study showed that ADAM10
co-immunoprecipitated with Tspan12 in human breast cancer
and neuroblastoma cell lines (24). Tspan12 also promoted
ADAM10maturation, which involves the cleavage of its prodo-
main by proprotein convertases during trafficking to the
plasmamembrane.Moreover, ADAM10 activity was enhanced
by Tspan12 as detected by shedding of the ADAM10 target
amyloid precursor protein (24). However, Tspan12 is unlikely
to be the only tetraspanin that regulates ADAM10 because it
does not share the ubiquitous expression profile of the metal-
loprotease, instead appearing relatively restricted to endothe-
lial cells of the retina,meninges of the brain, and smoothmuscle
cells of the colon (16). Indeed, Tspan12 does not appear to be
expressed by the platelet (25–29), a cell type on which we chose
to initially focus because it expresses many other tetraspanins
as well as ADAM10. Therefore, in the present study, we tested
the hypothesis that one or more platelet tetraspanins could
interact with and regulate ADAM10. This led to the identifica-
tion of a subgroup of six related, but largely unstudied, tetras-
panins that fulfilled these criteria that we termed the TspanC8
tetraspanins due to the eight cysteine residues within their
main extracellular region. These tetraspanins appear to play a
common role in promoting ADAM10 maturation and traffick-
ing to the plasma membrane.
EXPERIMENTAL PROCEDURES
Antibodies—Mouse anti-human mAbs were 11G2 (23) and
163003 (R&D Systems) to ADAM10, 11B1 to CD151 (30), IV.3
to FcRIIa (Medarex), and 1.3 to PECAM-1 (a gift from Peter
Newman, Wisconsin, MI). The rat anti-mouse ADAM10 mAb
was 139712 (R&D Systems), control mouse IgG1 was
MOPC-21 (Sigma), and control rat IgG2A was 54447 (R&D
Systems). Polyclonal antibodies were the AB936 goat anti-hu-
man ADAM10 (R&D Systems) and sc-6458 goat anti-VE-cad-
herin C terminus (Santa Cruz Biotechnology). Anti-epitope tag
antibodies were mouse anti-FLAG mAb M2 and rabbit anti-
FLAG (Sigma), rabbit anti-HA mAb C29F4 (Cell Signaling
Technology), and mouse anti-GFP mAb 3E1 (Cancer Research
UK).
Expression Constructs—Tetraspanin expression constructs
with N-terminal FLAG tags were generated by cloning tetras-
panin cDNAs into the pEF6-FLAG vector (27), which is a mod-
ified version of pEF6/Myc-His A (Invitrogen). Tetraspanin con-
structs withN-terminal GFP tags were similarlymade using the
pGFP-C vector (BioSignal Packard). Tetraspanin cDNAs were
generated by PCR from cDNA derived from the HEK293T cell
line, primary mouse megakaryocytes, or megakaryocyte-like
cell line L8057. Palmitoylation mutants of human tetraspanins
were generated by a two-PCR strategy (31) that mutated all
cysteine residues at the membrane-cytoplasm interface to ser-
ines. These were amino acids 13, 80, 89, and 95 for Tspan14; 12,
101, 287, 288, and 290 for Tspan15; and 81, 83, 92, and 100 for
Tspan33. TheHA-tagged bovineADAM10 in the pcDNA3vec-
tor has been described previously (32).
Mice—Tspan33/Penumbra knock-out mice have been
described previously (22). All animal maintenance and experi-
ments had appropriate Home Office approval and licensing
according to Animals (Scientific Procedures) Act 1986. Knock-
out mice and littermate controls were generated by breeding
heterozygote animals. All animals used for experiments were
aged 8 weeks or older.
Cell Culture andTransfection—All cell culture reagents were
from PAA unless stated. The human embryonic kidney (HEK)-
293T (HEK-293 cells expressing the large T-antigen of simian
virus 40) cell line was cultured in Dulbecco’s modified Eagle’s
medium (DMEM) containing 10% fetal bovine serum, 4 mM
glutamine, 100 units/ml penicillin, and 100 g/ml streptomy-
cin. Transfection ofHEK-293T cells was carried out using poly-
ethylenimine (Sigma) as described (33). The A549 human lung
epithelial cell line was cultured in the same medium as HEK-
293T cells. Primary human umbilical vein endothelial cells
(HUVECs) were provided by Phil Stone and Gerard Nash (Uni-
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versity of Birmingham) from umbilical cords that were
obtained with consent from the BirminghamWomen’s Health
Care National Health Service Trust after delivery. HUVECs
were maintained in M199 medium supplemented with 10%
fetal bovine serum, 4mM glutamine, 90g/ml heparin (Sigma),
and bovine brain extract (34) and used between passages 3 and
6 for all experiments. For siRNA knockdown experiments,
A549 and HUVECs were transfected using RNAiMAX trans-
fection reagent and 10 nM Silencer Select siRNA duplexes
(Invitrogen).
Purification of Platelets and Megakaryocytes—Washed
human platelets were prepared as described previously from
whole blood (35). Consent was obtained from each blood
donor, and platelet preparation was carried out in agreement
with the Declaration of Helsinki (2000) of the World Medical
Association and approved by the Ethics Committee at the Uni-
versity of Birmingham. Primary mouse megakaryocytes were
isolated using a modified version of the method described pre-
viously (36). Bone marrow was flushed under sterile conditions
from both femora and tibiae. Harvested cells were treated with
ACK red blood cell lysis buffer (0.15 M NH4Cl, 1 mM KHCO3,
0.1 mM Na2EDTA, pH 7.3) for 5 min at room temperature and
then filtered through a 70-m nylon mesh filter. To remove
non-megakaryocyte lineage cells, theywere incubated on ice for
30 min with rat anti-mouse mAbs to Gr-1, CD11b, B220, and
CD16/32 (eBioscience) and then depleted using anti-rat mag-
netic beads (Dynal). The remaining cells were cultured in com-
plete Stempro 34 medium (Invitrogen) supplemented with 20
ng/ml stem cell factor (PeproTech) for 48 h.Non-adherent cells
were transferred into fresh complete Stempro 34 medium and
supplemented with 20 ng/ml stem cell factor and 50 ng/ml
murine thrombopoietin (PeproTech). After a further 3–4 days
in culture, the differentiated cells were separated over a 1.5–3%
BSA gradient for 45 min, and the mature megakaryocytes were
collected from the bottom gradient fraction (36).
Purification of Proerythroblasts—Proerythroblasts were
purified from adult mouse bone marrow or fetal liver. For each
experiment that used proerythroblasts from adult mice, bone
marrowwas flushed from both femora and tibiae of three mice.
Cells were centrifuged at 300 g for 5 min at 4 °C, and the pellet
was resuspended in ice-cold 5–10%FBS in PBS. Fc receptorswere
blocked with anti-CD16/32 (eBioscience) for 5 min followed by
staining with allophycocyanin-conjugated anti-Ter119 and
phycoerythrin-conjugated anti-CD71 (eBioscience) for 60 min
on ice in the dark. Ter119 and CD71 double positive erythro-
blasts were collected using a Beckman Coulter MoFlo high
speed cell sorter. For preparation of proerythroblasts from fetal
liver, single cell suspensions of fetal liver cells fromE12.5mouse
embryoswere cultured as described (37). In brief, prepared cells
were cultured in Stempro 34 complete medium supplemented
with 100 ng/mlmurine stem cell factor (PeproTech), 2 units/ml
human erythropoietin (Roche Applied Science), and 1 M dex-
amethasone (Sigma) for 7 days. These cfu erythroid-enriched
cultures were purified using a Ficoll gradient and cultured in
the described medium for a further 2 days at which point the
cells were processed for MoFlo flow cytometry sorting as
described above.
Cell Surface Biotinylation Experiments—The human platelet
cell surface biotinylation experiments were conducted as
described (27). For mouse erythrocyte surface biotinylation
experiments, whole blood obtained by exsanguinations (35)
was centrifuged at 200 g for 5 min, and the erythrocytes were
separated from the platelet-rich plasma layer. Erythrocytes
were washed with modified Tyrode’s buffer containing 5% acid
citrate dextrose (35). The cells were biotinylated with 2 mM
EZ-Link sulfo-N-hydroxysuccinimide long chain biotin
(Thermo Scientific) for 30 min and quenched with 0.1 M gly-
cine. Subsequent cell lysis, immunoprecipitations, andWestern
blotting were as described (27). For ADAM10 stability studies,
A549 cells were transfected with siRNAs and 3 days later
were biotinylated with 1 mM EZ-Link sulfo-NHS-LC-biotin
(Thermo Scientific) for 30 min and quenched with 0.1 M gly-
cine. Some cells were harvested and frozen immediately,
whereas others were returned to culture and harvested and fro-
zen at 24, 36, or 48 h postbiotinylation. Cell pellets were lysed in
1% Triton X-100 lysis buffer (27) containing a protease inhibi-
tor mixture (Sigma). Following centrifugation to remove nuclei
and insoluble debris, lysates were subjected to mouse anti-
ADAM10 or control MOPC-21 immunoprecipitation for 90
min. The immunoprecipitates were washed with 1% Triton
X-100 lysis buffer, separated by SDS-PAGE on non-reducing
gels, and Western blotted with IRDye fluorescent neutravidin
(LI-COR Biosciences). The results were imaged and quantified
on theOdyssey Infrared Imaging System (LI-CORBiosciences).
Cell Surface Chemical Cross-linking Experiments—Two days
following transfection with HA-ADAM10 and FLAG-tetraspa-
nins, HEK-293T cells were washed with PBS and treated with a
2 mM concentration of the cell surface cross-linker 3,3-dithio-
bis(sulfosuccinimidylpropionate) (DTSSP) from Thermo
Fisher Scientific for 30 min on ice. The cross-linking was
quenched with 0.1 M glycine, and the cells were scraped off and
lysed in 1% Triton X-100 lysis buffer (27) containing a protease
inhibitor mixture (Sigma). Following centrifugation to remove
nuclei and insoluble debris, lysates were supplemented with
0.1% SDS to increase lysis buffer stringency, and mouse anti-
FLAG immunoprecipitations were performed overnight using
protein G-Sepharose beads (Invitrogen), or anti-GFP immuno-
precipitations were performed overnight using GFP-Trap
beads (ChromoTek). The immunoprecipitates were washed
with 1% Triton X-100, 0.1% SDS lysis buffer and separated by
SDS-PAGE on reducing gels to break the disulfide bond within
DTSSP, thus allowing co-immunoprecipitated proteins to run
at their predictedmolecular weights.Western blotting was car-
ried out with anti-HA and anti-FLAG or anti-GFP primary
antibodies and specific IRDye fluorescent secondary antibodies
(LI-COR Biosciences). The results were imaged and quantified
on theOdyssey Infrared Imaging System (LI-CORBiosciences).
Digitonin Lysis Experiments—These were done in a manner
similar to the experiments in the previous section except that
cells were not subjected to DTSSP cross-linking but were
instead directly lysed in 1% digitonin (Merck Millipore) lysis
buffer (38) containing a protease inhibitor mixture (Sigma).
Immunoprecipitations were done for 90 min rather than over-
night and were washed in 1% digitonin lysis buffer.
TspanC8 Subgroup Regulates ADAM10Maturation and Expression
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VE-cadherin Cleavage Assay—This assay was performed as
described (10) using HUVECs 3 days post-siRNA transfection.
The -secretase inhibitorN-[N-(3,5-difluorophenacetyl)-L-ala-
nyl]-S-phenylglycine t-butyl ester (Sigma) at 10 M was added
18 h before harvesting the cells to prevent further proteolysis
of VE-cadherin after ADAM10 cleavage. The results were
imaged and quantified on the Odyssey Infrared Imaging Sys-
tem (LI-COR Biosciences).
Flow Cytometry—For ADAM10 flow cytometry analyses of
mouse platelets and erythrocytes, whole blood was obtained by
exsanguinations (35), and 5-l volumes were stained in 50l of
PBS, 1 mM EGTA with 10 g/ml FITC-conjugated rat anti-
mouseADAM10mAbor negative control FITC-conjugated rat
IgG2A. Platelets and erythrocytes were analyzed using a FAC-
SCalibur (BD Biosciences) by first gating the cells according to
size. The level of ADAM10 expression on each cell type was
then calculated by subtracting the negative control geometric
mean fluorescence intensity from the specific ADAM10 value.
ADAM10 flow cytometry analyses of HUVECswere performed
by first scraping off the cells and then staining 1 105 cells with
10 g/ml FITC-conjugated mouse anti-human ADAM10mAb
or negative control FITC-conjugated mouse IgG1. Following
FACSCalibur analysis, the level of ADAM10 expression was
calculated as described above.
Quantitative PCR—RNA was isolated using the Norgen
Biotek Total RNA Purification kit and used to make cDNA
using the Invitrogen High Capacity cDNA Reverse Transcrip-
tase kit. Quantitative PCRs used a TaqMan 2 EnzymeMaster
Mix, TaqMan probes, and custom primers from Invitrogen.
Following 44 cycles in an ABI Prism 7000 Sequence Detection
System (Applied Biosystems), cycle threshold (Ct) values were
converted to Ct by subtracting Ct values for the glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) housekeeping
gene, and then Ct values were adjusted such that the highest
wild-type value averaged to 100.
Bioinformatics and Statistical Analyses—Multiple sequence
alignment of protein sequences of the 33 human tetraspanins
was conducted using Clustal Omega (39). Statistical analyses
were carried out using a one-way analysis of variance followed
by Dunnett’s test.
RESULTS
ADAM10 Associates with Tetraspanins in Platelets—The
ectodomain sheddase ADAM10 has been reported to associate
with tetraspanins in a variety of cell lines (23, 24). The platelet
was initially selected as a good model for a human cell line that
expresses ADAM10 and multiple tetraspanins. Thus, to deter-
mine whether ADAM10 interacts with tetraspanins on human
platelets, they were surface-biotinylated and subjected to lysis
in two different detergents: 1% Brij97, which largely retains tet-
raspanin-tetraspanin interactions, and the more stringent 1%
Triton X-100, which disrupts tetraspanin-tetraspanin interac-
tions (12). Following immunoprecipitation ofADAM10or con-
trol proteins, co-immunoprecipitated surface proteins were
detected by streptavidin Western blotting. Under Brij97 lysis,
ADAM10was found to co-immunoprecipitate a pattern of pro-
teins strikingly similar to CD151 (Fig. 1), which was chosen
because it is the best characterized platelet tetraspanin (21).
This pattern of ADAM10- and CD151-associated proteins was
lost inmore stringent TritonX-100 lysis buffer (Fig. 1), suggest-
ing that the observed bands represent the main components of
tetraspanin microdomains. In contrast to ADAM10 and
CD151, immunoprecipitations of FcRIIa and PECAM-1
yielded the proteins themselves but no major associated pro-
teins (Fig. 1). These were chosen as controls because they are
not known to associate with tetraspanins but have expression
levels comparable to that of ADAM10 (Fig. 1). These data sug-
gest that ADAM10 is a component of platelet tetraspanin
microdomains but provide no evidence for a direct ADAM10-
CD151 interaction. Indeed, such a direct interaction would
appear unlikely because itwas not retained inTritonX-100 lysis
buffer. Instead, one or more other platelet tetraspanins may
directly interact with ADAM10 and act to bridge indirect
ADAM10-CD151 interactions.
The Platelet Tetraspanins Tspan14, Tspan15, and Tspan33
Interact with and Promote ADAM10 Maturation—Tspan12
was reported to interact more strongly with ADAM10 than
other tetraspanins that were tested (CD9, CD81, CD82, and
CD151) and to promote ADAM10 maturation (24). However,
Tspan12 is not as ubiquitously expressed asADAM10 (16), sug-
gesting that ADAM10 might be regulated by additional tetras-
panins. Indeed, an extensive proteomics analysis of the human
platelet cell surface did not detect Tspan12 but did identify at
least 10 other tetraspanins (26, 29). In addition, recent platelet
transcriptomics profiling (28) found mRNA for 22 and 21 tet-
raspanins in human and mouse, respectively, but Tspan12 was
not among the human tetraspanins and was only very weakly
detected in mouse (supplemental Fig. I).
To determine whether one or more platelet tetraspanins
could interact with ADAM10, a panel of 10 was selected based
on their identification on human platelets by proteomics (26,
29). Because antibodies are not available to most of these tet-
raspanins, a co-transfection system in HEK293T cells was
FIGURE 1. ADAM10 is a component of tetraspanin microdomains on
platelets because ADAM10 immunoprecipitates from platelet lysates
contain a characteristic pattern of tetraspanins and associatedproteins.
Human platelets were surface-biotinylated and lysed in 1% Brij97 lysis buffer
(labeled B), which largely maintains tetraspanin-tetraspanin interactions and
hence microdomain integrity, or in 1% Triton X-100 (labeled T), which dis-
rupts tetraspanin microdomains (12). Lysates were immunoprecipitated (i.p)
with negative control IgG or mAbs to ADAM10, tetraspanin CD151 (positive
control), FcRIIa, or PECAM-1 (non-tetraspanin-associated negative control).
Immunoprecipitates were analyzed by streptavidin Western blotting to
detect biotinylated proteins. The separating line between the FcRIIa and
PECAM-1 data indicates that the latter was from a different part of the same
gel.
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adopted using FLAG epitope-tagged tetraspanins and
HA-tagged ADAM10. This was followed by surface chemical
cross-linking with DTSSP with the aim of capturing direct tet-
raspanin-ADAM10 associations and co-immunoprecipitation
under highly stringent lysis conditions (1%Triton, 0.1% SDS) to
retain only cross-linked interactions. Importantly, DTSSP con-
tains a disulfide bond that can be broken by reducing agents,
thus allowing individual proteins to be detected by Western
blotting at their appropriate molecular weights. This surface
chemical cross-linking protocol has the added benefit of
restricting the analysis to surface proteins, therefore avoiding
intracellular aggregated proteins that can be a problem in tran-
sient transfection of HEK-293T cells. Following immunopre-
cipitation of the 10 tetraspanins, Tspan14, Tspan15, and
Tspan33 shared the capacity to immunoprecipitate signifi-
cantly more surface ADAM10 than the others (Fig. 2A). These
three tetraspanins each interacted preferentially with the low
molecular weight form of ADAM10, which corresponds to
matureADAM10with a cleaved prodomain. In addition,West-
ern blotting of whole cell lysates showed that Tspan14,
Tspan15, and Tspan33 each promoted significant maturation
of ADAM10 (Fig. 2B). Finally, expression of each tetraspanin
was confirmed, albeit at levels that varied from relatively strong
for CD9, Tspan14, Tspan15, and Tspan33 to relatively weak for
Tspan2, which was only detectable upon longer exposures (Fig.
2C anddata not shown). Taken together, these data suggest that
among platelet tetraspanins Tspan14, Tspan15, and Tspan33
interact with ADAM10 and promote its maturation. This is the
first reported function for Tspan14 or Tspan15; a gene knock-
out study has demonstrated an essential role for Tspan33 in
mouse erythropoiesis (22).
Tetraspanin Palmitoylation Is Not Required for Tspan14,
Tspan15, and Tspan33 to Promote ADAM10 Maturation—
Palmitoylation of tetraspanins on multiple cysteine residues at
their transmembrane-cytoplasmic junctions is known to pro-
mote tetraspanin-tetraspanin interaction and the formation of
tetraspaninmicrodomains. Indeed, mutation of these cysteines
impairs tetraspanin-tetraspanin interactions (12). If such
mutants ofTspan14,Tspan15, andTspan33 retained the capac-
ity to regulate ADAM10, this would provide additional evi-
dence in favor of a direct interaction (that is, an interaction that
is not due to chemical cross-linking of a complex of proteins
containing transfected proteins and endogenous tetraspanins
that act as linkers). Interestingly, the previously reported regu-
lation of ADAM10 by Tspan12 was dependent on palmitoyla-
tion of the latter (24), raising the possibility that the observed
interaction was indirect. In an experiment with the samemeth-
odology as that shown previously in Fig. 2,A–C, palmitoylation
mutants ofTspan14,Tspan15, andTspan33 retained the capac-
FIGURE 2. Tspan14, Tspan15, and Tspan33 interact with and promote the maturation of ADAM10. A–C, HEK-293T cells were transfected with FLAG-
tagged mouse forms of a panel of 10 tetraspanins previously found to be expressed by human platelets (26, 29) in the absence () or presence () of
HA-tagged bovine ADAM10. The cells were surface-cross-linkedwith DTSSP, lysed in 1%Triton X-100, and subjected to anti-FLAG immunoprecipitation (i.p) in
1% Triton X-100 containing 0.1% SDS. A, the immunoprecipitates were reduced to break the cross-linker, and ADAM10 was detected by anti-HA Western
blotting. The immature (upper band) andmature (lower band) formsofADAM10weredetectedandquantifiedusing theOdyssey Infrared ImagingSystem from
LI-COR Biosciences, and a graph is presented to show the mean total ADAM10 with S.E. from three experiments (**, p  0.01 compared with all other
tetraspanins). B, ADAM10 inwhole cell lysates was similarly analyzed by anti-HAWestern blotting, and a graph is presented to show the percentage ofmature
ADAM10 for each transfection (n  3; **, p  0.01 compared with ADAM10 only; error bars represent S.E.). C, expression of tetraspanins was confirmed by
anti-FLAG Western blotting. The tetraspanins varied in their expression levels; Tspan2 was not readily detected in this figure but was detectable on longer
exposures (data not shown). D–F, palmitoylation of Tspan14, Tspan15, and Tspan33 is not essential for ADAM10 interaction or promotion of maturation. The
experiment was performed as described in A–C except that wild-type (WT) and palmitoylationmutant (PM) forms of human tetraspanins were compared, and
the experiment was performed in 1% digitonin lysis buffer in the absence of DTSSP cross-linking (data are representative of three experiments; **, p 0.01).
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ity to interact with surface ADAM10 and to promote its matu-
ration (supplemental Fig. II).
To provide further evidence in support of these observations,
co-immunoprecipitations were performed from non-cross-
linked cells lysed in 1% digitonin. This is a detergent that pre-
cipitates cholesterol and large tetraspanin complexes but in
which smaller tetraspanin-partner interactions appear to
remain soluble (38). Indeed, digitonin has previously proved
useful in identifying tetraspanin-partner interactions (12).
Under digitonin lysis conditions, Tspan14, Tspan15, and
Tspan33 co-immunoprecipitated robustly with ADAM10 in a
manner that did not require palmitoylation of the tetraspanins
(Fig. 2D). Promotion of ADAM10 maturation also did not
require palmitoylation (Fig. 2E). As controls, mutation of
palmitoylation sites did not affect tetraspanin expression (Fig.
2F), andCD9 failed to co-immunoprecipitate withADAM10 or
promote its maturation (Fig. 2, D–F). Taken together, these
data are consistent with a direct interaction between ADAM10
and the tetraspanins Tspan14, Tspan15, and Tspan33.
Tspan14, Tspan15, and Tspan33 Are Members of the
TspanC8 Subgroup of Tetraspanins—Tspan14, Tspan15, and
Tspan33 share a relatively high protein sequence identity of
between 31 and 39% in human and belong to a subgroup of six
related tetraspanins that includes the functionally uncharacter-
ized Tspan5, Tspan10, and Tspan17 (Fig. 3A). These six tetras-
panins have eight cysteine residues within their main extracel-
lular region unlike other tetraspanins that have four, six, or
seven. These cysteines appear to be structurally important
through the formation of disulfide bonds (12). Hence, we have
termed these six tetraspanins the TspanC8 subgroup.
To determinewhether all six TspanC8 tetraspanins share the
capacity to interact with and promote ADAM10 maturation,
ADAM10 was co-transfected into HEK-293T cells with each
TspanC8 tetraspanin, and ADAM10 co-immunoprecipitation
and maturation following digitonin lysis were detected by
Western blotting as described in Fig. 2, D–F. The TspanC8
tetraspanins each interacted with ADAM10, but control tetras-
panins CD9, CD151, and Tspan9 did not (Fig. 3B). Among the
TspanC8 tetraspanins, Tspan10 interacted with ADAM10 rel-
atively poorly (Fig. 3B), which was consistently observed in
three experiments (data not shown). Nevertheless, each
TspanC8 tetraspanin promoted significant ADAM10 matura-
tion unlike the non-TspanC8 tetraspanin controls (Fig. 3C),
and expression of the tetraspanins was confirmed in Fig. 3D.
These data suggest that the six TspanC8 tetraspanins share a
common function in regulating ADAM10.
Tspan12 is not a TspanC8 tetraspanin (Fig. 3A) but was
reported previously to promote ADAM10 maturation (24).
However, this study did not include any TspanC8 tetraspanins
that would have allowed their comparison with Tspan12. To
address whether TspanC8 tetraspanins and Tspan12 interact
with ADAM10 and promote maturation in a comparable man-
ner, interaction and maturation were measured by co-immu-
noprecipitation in digitonin lysis buffer. In these experiments,
FIGURE3.Tspan14,Tspan15,andTspan33aremembersof theTspanC8subfamilyof tetraspanins,which includesTspan5,Tspan10,andTspan17,and
each can interact with and promote ADAM10maturation. A, amino acid sequences of the 33 human tetraspanins were analyzed by themultiple sequence
alignment tool Clustal Omega, which is a recently improved version of ClustalW (39), and the data are presented as a dendrogram. B–D, HEK-293T cells were
transfected with HA-tagged bovine ADAM10 and FLAG-tagged forms of the six mouse TspanC8 and three non-TspanC8 tetraspanins. Cells were lysed in 1%
digitonin and subjected to anti-FLAG immunoprecipitation (i.p) followedby anti-HA and anti-FLAGWestern blotting. Quantification anddata presentation are
as described in Fig. 2, A–C. The data are representative of three experiments (**, p 0.01; error bars represent S.E.).
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the amount of transfected FLAG-Tspan14was titrated down to
allow comparison with the relatively poorly expressed FLAG-
Tspan12. Unlike Tspan14, Tspan12 did not interact with
ADAM10 (Fig. 4A) or induce ADAM10 maturation (Fig. 4B)
despite similar expression levels at the lower end of the
Tspan14 titration (Fig. 4C). In a complimentary set of experi-
ments, GFP-tagged tetraspanins were used because GFP-
Tspan12 was expressed at a level comparable with that of GFP-
Tspan14, and the DTSSP cross-linking method was used as
described previously in Fig. 2,A–C (supplemental Fig. III). Con-
sistent with FLAG-Tspan12 in Fig. 4, GFP-Tspan12 failed to
interact withADAM10 or promote itsmaturation (supplemen-
tal Fig. III). Taken together with the previously published data,
this suggests that although Tspan12 can induce ADAM10mat-
uration under some circumstances the TspanC8 tetraspanins
may be the major tetraspanin regulators of ADAM10.
Tspan14 Is the Major TspanC8 Tetraspanin in HUVECs and
Is Essential for Normal ADAM10 Surface Expression—Because
overexpression of TspanC8 tetraspanins promotes ADAM10
maturation, a process that occurs during ADAM10 trafficking
to the plasma membrane, it is possible that TspanC8 tetraspa-
nins are required for such trafficking. This would be compara-
ble with the way in which other tetraspanins are known to pro-
mote trafficking of other partners (12, 40). To test this theory,
siRNA knockdown of TspanC8 tetraspanins was carried out
followed by flow cytometry to detect surface ADAM10 expres-
sion. Because siRNA knockdown is not possible in platelets,
primary HUVECs were selected because of the importance of
ADAM10 in endothelial cell function (1). To initially determine
the relative expression levels of TspanC8 tetraspanins in
HUVECs, RT-PCRwas carried out because effective antibodies
are not available to any TspanC8 tetraspanin. Tspan14 mRNA
was found to be more abundant than the rest of the TspanC8
tetraspanins combined (Fig. 5A). These data were comparable
with next generation sequencing of HUVECs that yielded the
following number of mRNA transcripts per million: 9.1 for
Tspan5, 0.1 for Tspan10, 56.9 for Tspan14, 14.6 for Tspan15,
24.7 for Tspan17, and 0 for Tspan33.3 Tspan14 knockdown
with two different siRNA duplexes was found to decrease
Tspan14 mRNA by over 75% as detected by RT-PCR (Fig. 5B).
More importantly, each significantly reduced surfaceADAM10
by over 50% (Fig. 5,C andD). It is possible that residual Tspan14
and other TspanC8 tetraspanins in these cells is the reason why
the reduction in surface ADAM10 was not complete.
To determine the effect of Tspan14 knockdownonADAM10
activity, HUVEC lysates were Western blotted for the
ADAM10 substrate VE-cadherin (10). Tspan14 knockdown
significantly reduced VE-cadherin cleavage in line with the
reduction in ADAM10 expression level (Fig. 5, E and F). As an
additional control, VE-cadherin cleavage was further reduced
by ADAM10 knockdown (Fig. 5, E and F), and the level of
ADAM10 protein knockdown was almost 100% as detected by
flow cytometry (Fig. 5C). In combination with the flow cytom-
etry data, these ADAM10 activity data are consistent with the
idea that TspanC8 tetraspanins are essential for normal
ADAM10 surface expression.
ADAM10 Stability in the A549 Cell Line Is Not Reduced fol-
lowing Tspan14 Knockdown—The reduced ADAM10 surface
expression following Tspan14 knockdown could be due to
impaired trafficking to the cell surface and/or reduced stability.
To address the latter possibility, a cell surface biotinylation
assay was used in Tspan14 knockdown A549 human lung epi-
thelial cells. This cell line was chosen for these experiments
because its TspanC8 tetraspanin profile is similar to that of
HUVECs (Fig. 6A). In addition,A549 has the advantage of being
a faster growing cell line that is more amenable to biochemical
analyses than primary HUVECs. Similar to HUVECs, Tspan14
knockdown significantly reduced the level of surface ADAM10,
which in this case was detected by surface biotinylation and
ADAM10 immunoprecipitation followed by neutravidinWest-
ern blotting (Fig. 6, B and C). However, there was no evidence
for increased ADAM10 degradation following Tspan14 knock-
down relative to negative control siRNA over 24, 36, and 48 h
postbiotinylation (Fig. 6B). Instead, quantitation revealed that
loss of biotinylated ADAM10 over time appeared slightly
slower following Tspan14 knockdown (Fig. 6C). These data
suggest that impaired ADAM10 trafficking to the cell surface is
the main consequence of Tspan14 knockdown.
Tspan33 Is the Major TspanC8 Tetraspanin in the Erythrocyte
Lineage and Is Essential for Normal ADAM10 Expression—
To determine whether TspanC8 tetraspanins regulate
ADAM10 in vivo, ADAM10 expressionwas investigated in cells
from the Tspan33-deficient mouse, which is the only currently
available knock-outmouse for a TspanC8 tetraspanin (22). The
two major blood cell types, platelets and erythrocytes, were
selected as the subjects of this analysis because their relative
Tspan33 expression levels were likely to be quite distinct;
Tspan33 mRNA is expressed by mouse erythrocytes (22) but is
3 J. M. Herbert and R. Bicknell, unpublished data.
FIGURE 4. The non-TspanC8 tetraspanin Tspan12 does not interact with
orpromoteADAM10maturation.HEK-293T cellswere transfectedwithHA-
tagged bovine ADAM10 and FLAG-taggedmouse forms of the non-TspanC8
tetraspanins Tspan12 or CD9 or a titration of the TspanC8 tetraspanin
Tspan14. Cells were lysed in 1% digitonin and subjected to anti-FLAG immu-
noprecipitation (i.p) followedby anti-HAWestern blotting of immunoprecipi-
tates (A) and whole cell lysates (B) and anti-FLAG blotting of immunoprecipi-
tates (C).
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minimal in mouse platelets (supplemental Fig. I). To test this
hypothesis, TspanC8 tetraspanin mRNA levels were measured
by RT-PCR in mouse megakaryocytes and erythroid progeni-
tors because mature platelets and erythrocytes carry relatively
small amounts of mRNA. Tspan33 expression in mouse mega-
karyocytes was almost undetectable in contrast to the relatively
high expression of Tspan14 and weaker expression of Tspan5
and Tspan17 (Fig. 7A). Conversely, Tspan33 was the major
TspanC8 tetraspanin in erythroid progenitors compared with
almost undetectable levels of Tspan5 andTspan14 (Fig. 7B). No
compensatory up-regulation of other TspanC8 tetraspanins
was apparent in Tspan33-deficient cells (data not shown). As a
control, primer/probe efficiencies were found to be similar for
each TspanC8 tetraspanin (supplemental Fig. IV).
Consistent with the extremely low relative level of Tspan33
in megakaryocytes, ADAM10 surface expression was normal
on Tspan33-deficient mouse platelets (Fig. 7C). In contrast,
Tspan33-deficient erythrocytes exhibited an approximate 90%
reduction in surface ADAM10 (Fig. 7D), which was consistent
with similarly reduced whole cell ADAM10 expression as
determined by Western blotting (Fig. 7E). Importantly, defec-
tive ADAM10 protein expression was not due to any reduction
in ADAM10mRNA in the erythroid lineage (Fig. 7F). Together
these data demonstrate that TspanC8 tetraspanins regulate
ADAM10 in vivo. The distinct repertoires of TspanC8 tetras-
panins in different cell types may allow ADAM10 targeting to
specific substrates andmay ultimately be exploited in therapies
that target specific TspanC8-ADAM10 complexes.
FIGURE 5. Surface ADAM10 expression is reduced upon knockdown of themajor HUVEC TspanC8 tetraspanin Tspan14. A, themRNA levels of TspanC8
tetraspanins in HUVECs were measured by RT-PCR (n 2; error bars represent S.E.). B, HUVECs were transfected with negative control siRNA or two different
Tspan14 siRNAs. Tspan14 knockdown was assessed by RT-PCR (n  2; error bars represent S.E.). C, HUVEC surface ADAM10 levels were measured by flow
cytometry in the transfected cells from B. Representative histograms include an ADAM10 knockdown as a control. For each histogram, the ADAM10 trace is in
black, and the isotype antibody control is ingray.D, thedata inC are alsopresented as abar chart showingmeanADAM10 levels andS.E. from twoexperiments.
E and F, HUVECs were transfected with negative control siRNA or two different Tspan14 or ADAM10 siRNAs. Whole cell lysates were subjected to Western
blotting for the cytoplasmic tail of the ADAM10 substrate VE-cadherin (E). A graph shows the mean percentage of cleaved ADAM10 with S.E. from three
experiments (F) (*, p 0.05; **, p 0.01 compared with the non-transfected control).
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DISCUSSION
The metalloprotease ADAM10 cleaves over 40 transmem-
brane targets, including the platelet-activating collagen recep-
tor glycoprotein VI (7, 8). Because ADAM10 is compartmen-
talized into tetraspanin membranes on various cell types (23,
24), including platelets (Fig. 1), the present study beganwith the
hypothesis that one or more platelet tetraspanins would specif-
ically associate with and regulate ADAM10. This hypothesis
was proved correct by the discovery that three platelet tetras-
panins could interact with and promote ADAM10 maturation.
These were Tspan14, Tspan15, and Tspan33, the former two of
which were previously uncharacterized. Because of their rela-
tively strong sequence identities, including eight cysteine resi-
dues within their major extracellular region, they were named
the TspanC8 subgroup of tetraspanins. This subgroup contains
three other uncharacterized tetraspanins, Tspan5, Tspan10,
and Tspan17, which each were able to interact with and pro-
mote ADAM10 maturation. Furthermore, analyses of the only
available knock-out mouse for a TspanC8 tetraspanin
(Tspan33) and tetraspanin knockdown in cultured primary
endothelial cells demonstrated an essential role for TspanC8
tetraspanins in ADAM10 trafficking to the cell surface.
Reduced endothelial cell surface ADAM10 correlated with
reduced activity toward its substrate (VE-cadherin). This study
has therefore defined a function for a largely uncharacterized
subgroup of tetraspanins and has identified a novel global reg-
ulatory mechanism for ADAM10.
The hypothesis behind this work was conceived following
two previous reports that ADAM10was tetraspanin-associated
in leukocyte, breast cancer, and neuroblastoma cell lines (23,
24). Moreover, Tspan12 was proposed as an ADAM10-inter-
acting tetraspanin (24). However, because ADAM10 appears to
be ubiquitous but Tspan12 is not (16), it seemed likely that
other tetraspanins would interact with ADAM10. Analyses of
the Tspan12-deficientmouse did not address a potential role in
ADAM10 regulation but instead demonstrated a role for
Tspan12 in the regulation of Frizzled-4-induced -catenin sig-
naling (16). Tspan12 deficiency leads to defective vascular
development in the retina, and Tspan12 mutations cause the
human blinding disease familial exudative vitreoretinopathy,
thus phenocopying mutations in the Frizzled-4 signaling path-
way (17, 18). To address whether Tspan12 could regulate
ADAM10 in a manner comparable with that of TspanC8 tet-
raspanins, Tspan12 was compared with Tspan14 for its capac-
ity to interact with and promote ADAM10 maturation. Using
two different transiently transfected Tspan12 constructs
(FLAG- and GFP-tagged) in two different types of co-immuno-
precipitation experiment (digitonin lysis or DTSSP surface
cross-linking), Tspan12 appeared unable to interact with
ADAM10 and promote its maturation. How can this finding be
resolved with the previous, apparently contradictory publica-
tion (24)? It is possible that this earlier finding was a conse-
quence of up-regulation of TspanC8 expression at the tran-
scriptional level due to the stable Tspan12 transfection used in
the study (24). Tspan12 transfection can certainly promote
Frizzled-4-induced-catenin signaling in a cell linemodel (16),
and this could in theory induce the transcription of one ormore
TspanC8 tetraspanins. This could facilitate indirect Tspan12
interaction with ADAM10 and maturation of the latter (24). A
candidate is Tspan5, which was identified as a -catenin target
gene in amicroarray screenof colorectal cancer cells (41).Consist-
ent with the theory that the previously observed Tspan12-
ADAM10 interaction could be bridged by a TspanC8 tetraspanin,
the interactionwas only detected in relatively non-stringent lysis
FIGURE 6. Tspan14 knockdown in the A549 epithelial cell line does not
reduce ADAM10 stability. A, the mRNA levels of TspanC8 tetraspanins in
A549 cells weremeasured by RT-PCR (n 2; error bars represent S.E.). B, A549
cells were transfected with negative control siRNA or two different siRNAs to
Tspan14, the major TspanC8 tetraspanin in this cell type. Cells were surface-
biotinylated and lysed at 0, 24, 36, and 48 h postbiotinylation. Lysates were
subjected to immunoprecipitation (i.p) with ADAM10 or negative control
mAbs and then Western blotted with neutravidin to detect biotinylated
ADAM10, the size ofwhich corresponds to themature form. Theblot shown is
representative of three experiments. C, ADAM10 levels from B and two addi-
tional experiments were quantified using the Odyssey Infrared Imaging Sys-
tem, and a graph is presented to show the mean level of biotinylated
ADAM10 with S.E. (n 3; *, p 0.05 for control siRNA versus Tspan14 siRNA
knockdowns).
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conditions (0.5% Brij97) (24) that would maintain tetraspanin-
tetraspanin interactions (12). Indeed, the interaction and
ADAM10 maturation were lost upon mutation of the Tspan12
palmitoylation sites (24), which are required for normal tet-
raspanin-tetraspanin association (12). Importantly, muta-
tion of palmitoylation sites in the TspanC8 tetraspanins did not
abolish maturation of ADAM10 or significantly inhibit the
interaction in the present study, suggesting that these are bona
fide ADAM10-interacting tetraspanins.
The key finding that TspanC8 tetraspanin deficiency results
in reduced ADAM10 cell surface expression could potentially
be due to impaired trafficking to the plasma membrane and/or
reduced ADAM10 stability. Reduced stability is unlikely to be
involved because knockdown of Tspan14, the major TspanC8
FIGURE7.RegulationofADAM10expressionbyTspanC8 tetraspanins in theplatelet anderythrocyte lineages.A, Tspan33 is relativelyweakly expressed
in the megakaryocyte/platelet lineage. The mRNA levels of TspanC8 tetraspanins in megakaryocytes isolated fromwild-type mice were measured by RT-PCR
(n 4; error bars represent the S.E.). B, Tspan33 is relatively highly expressed in the erythroid lineage. The mRNA levels of TspanC8 tetraspanins in proeryth-
roblasts isolated from wild-type mice were measured by RT-PCR (n  3; error bars represent the S.E.). C, ADAM10 surface protein expression is normal on
Tspan33-deficient platelets. Whole blood from WT and Tspan33 knock-out (T33 KO) mice was analyzed by flow cytometry for ADAM10, and platelets were
gated by size. Representative histograms show the ADAM10 trace in black and the isotype control antibody in gray. The mean ADAM10 expression from five
experiments is also presented as a bar chart (error bars represent the S.E.). D, erythrocyte surface ADAM10 expression is reduced by90% in the absence of
Tspan33. Whole blood fromWT and Tspan33 knock-out (T33 KO) mice was analyzed by flow cytometry for ADAM10, and erythrocytes were gated by size with
the data presented as in C (n  5; ***, p  0.001; error bars represent the S.E.). E, whole cell ADAM10 expression is reduced in the absence of Tspan33.
Erythrocytes fromWT and Tspan33 knock-out (T33 KO) mice were surface-biotinylated, lysed in 1% Brij97 lysis buffer, and subjected to immunoprecipitation
(i.p) with isotype control or anti-ADAM10 antibody. The immunoprecipitates were Western blotted with neutravidin to detect biotinylated proteins (upper
panel) orADAM10antibody (lower panel), the latter ofwhich corresponded to themolecularweightofmatureADAM10. F, ADAM10mRNAexpression is normal
in Tspan33-deficient erythroid progenitors. ADAM10 mRNA levels in proerythroblasts from WT and Tspan33 knock-out (T33 KO) mice were measured by
RT-PCR (n 3; error bars represent the S.E.).
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tetraspanin in the A549 epithelial cell line, failed to show any
increased ADAM10 degradation over time using a cell surface
biotinylation approach. Importantly, ADAM10 surface expres-
sion was significantly reduced by Tspan14 knockdown at the
beginning of the experiment. Therefore, TspanC8 tetraspanins
are likely to promote ADAM10 trafficking to the cell surface.
Promotion of partner trafficking is emerging as a general con-
cept in tetraspanin biology. For example, tetraspanin CD81 is
essential for normal surface trafficking of CD19, a key compo-
nent of B cell receptor signaling, such that mutation of CD81 in
humans results in a loss of surface CD19 and profound immu-
nodeficiency (40). An important question that arises from the
current study concerns the mechanism by which the TspanC8
tetraspanins promote trafficking of ADAM10 to the cell sur-
face. ADAM10 was recently shown to possess an arginine-
based endoplasmic reticulum (ER) retention motif that pre-
vents efficient trafficking of the metalloprotease to the cell
surface (42). However, it was not clear from that study how the
retention motif is overcome and ADAM10 is released from the
ER.One theory in the study of such arginine-basedER retention
motifs is that they can be masked upon successful interaction
with a partner protein, which then allows the correctly assem-
bled complex to be transported from the ER (43). It is therefore
possible that ADAM10 is retained in the ER until interaction
with a TspanC8 tetraspanin, which masks the retention motif.
A striking finding from the present study was that asmany as
six tetraspanins could regulateADAM10. Such functional com-
pensation among tetraspanins is not without precedent albeit
on a smaller scale. The clearest example is for the related tet-
raspanins CD9 and CD81, which share 44% protein sequence
identity in human and share some common partners, namely
the immunoglobulin superfamily proteins EWI-2 and EWI-F
(CD9P-1) (12). CD81was shown to partially compensate for the
fertilization defect observed in CD9-deficient mice (12). In
addition, a role for these tetraspanins in the maintenance of
normal lung function was only revealed by the observation of a
chronic obstructive pulmonary disease-like phenotype in the
double knock-out mouse but not in either of the single knock-
outs (44). Compensation between TspanC8 tetraspanins is
likely to complicate future analyses of knockdown cells and
knock-out animals. An additional problem is the lack of effec-
tive antibodies to any TspanC8 tetraspanin, which leaves RT-
PCR as the current best option for quantifying mRNA expres-
sion levels in different cell types. This techniquewas used in the
present study to demonstrate that Tspan33 and Tspan14 are
the major TspanC8 tetraspanins in mouse erythroid cells and
HUVECs, respectively. This explains the striking reductions in
surface ADAM10 on erythrocytes and HUVECs deficient for
these tetraspanins. The Tspan33-deficient mice used in this
study exhibit impaired erythropoiesis (22), but it is currently
unclear whether an90% reduction in surface ADAM10 could
be responsible for this phenotype. Finally, ADAM10 was found
to be normally expressed on the surface of platelets from these
mice, which was consistent with the almost undetectable level
of Tspan33mRNA in their megakaryocyte precursors. Because
Tspan14 is the major TspanC8 tetraspanin in this lineage,
defective platelet ADAM10 expression in a Tspan14 knock-out
mouse would be predicted.
ADAM10 has considerable therapeutic potential due to the
important roles of its many target proteins in inflammation,
thrombosis, cancer, and Alzheimer disease (1, 4). Despite its
potential in therapy, all clinical trials involving ADAM10 have
so far failed due to problems with toxicity (4). However, this
study has identified the TspanC8 tetraspanins as the regulators
of ADAM10maturation and trafficking to the cell surface. The
ADAM10 interaction with six TspanC8 tetraspanins may have
evolved to allow targeting of ADAM10 to specific substrates or
compartments within the cell. Targeting specific TspanC8 tet-
raspanin-ADAM10 complexes raises the possibility of targeting
themetalloprotease in a cell type- or substrate-specificmanner.
Such an approach could target specific disease processes such
as cancer, Alzheimer disease, and cardiovascular disease while
minimizing problems with toxicity.
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Addendum—Prox et al. (45) have recently identified the TspanC8
tetraspanin Tspan15 in a screen for ADAM10-interacting proteins.
Consistent with our data on Tspan14, Tspan33, and other TspanC8
tetraspanins, Tspan15was found to promoteADAM10 exit from the
endoplasmic reticulum, maturation, cell surface expression, and
activity (45).
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